Publications by authors named "Geoff Dusheiko"

Claim this Profile
P
Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis.
Seth Inzaule, Philippa Easterbrook, Ashley Latona, Nathan P Ford, William Irving, Geoff Dusheiko

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi-ethnic population: Universal screening is more comprehensive.
Ivana Carey, Moigboi Christiana, McLeod Marie-Ange, Bowyer Teresa, Guerra Veloz Maria, Geoff Dusheiko

J Viral Hepat· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.
Rachel Hung, Nisha Patel, Julie Fox, Catherine Cosgrove, Sarah L Pett, Geoff Dusheiko

AIDS· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification in chronic hepatitis B patients for hepatocellular carcinoma surveillance: management in migrant sub-Saharan African populations.
Zillah Cargill, Sarah E Brown, Geoff Dusheiko, Kosh Agarwal

Gut· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Micro-elimination of HIV and HCV co-infection.
Geoff Dusheiko, Kate Childs

Lancet HIV· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
Michelle Spaan, Ivana Carey, Matthew Bruce, Dazhuang Shang, Mary Horner, Geoff Dusheiko

J Hepatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action".
Kate Childs, Mary Cannon, Christopher Davis, Emma C Thompson, Geoff Dusheiko

J Hepatol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C.
Kate Childs, Christopher Davis, Mary Cannon, Sarah Montague, Ana Filipe, Geoff Dusheiko

J Hepatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
Graham S Cooke, Isabelle Andrieux-Meyer, Tanya L Applegate, Rifat Atun, Jessica R Burry, Geoff Dusheiko

Lancet Gastroenterol Hepatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders.
Kumar Visvanathan, Geoff Dusheiko, Michelle Giles, May-Ling Wong, Nghi Phung

Gut· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom.
Sarah L Bermingham, Ralph Hughes, Elisabetta Fenu, Laura M Sawyer, Elizabeth Boxall, Geoff Dusheiko

Value Health· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telaprevir or boceprevir based therapy for chronic hepatitis C infection: development of resistance-associated variants in treatment failure.
Malcolm J Macartney, Dianne Irish, Simon H Bridge, Ana Garcia-Diaz, Clare L Booth, Geoff Dusheiko

Antiviral Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus.
Steven T Wiersma, Brian McMahon, Jean-Michel Pawlotsky, Chloe L Thio, Mark Thursz, Geoff Dusheiko

Liver Int· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
Helen Dakin, Anthony Bentley, Geoff Dusheiko

Value Health· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-emergent hepatitis C viremia after apparent clearance in HIV-positive men who have sex with men: reinfection or late recurrence?
Rachael Jones, David Brown, Mark Nelson, Emma Low, Sanjay Bhagani, Geoff Dusheiko

J Acquir Immune Defic Syndr· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamivudine combined with hepatitis B immunoglobulin in for prophylaxis of hepatitis B recurrence after liver transplantation: time for a change?
Helena N Deeney, Geoff M Dusheiko

Transpl Int· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Missed opportunities: Undiagnosed HIV infection in patients with viral hepatitis.
Anna Maria Geretti, Sara Madge, Marcus Posner, Geoff Dusheiko, Michael Jacobs

BMJ· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opiate abuse and viral replication in hepatitis C.
Kevin Moore, Geoff Dusheiko

Am J Pathol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.
Ali Judd, John Parry, Matthew Hickman, Tamara McDonald, Laura Jordan, Geoff Dusheiko

J Med Virol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.
Michaela Lucas, Stephan Gadola, Ute Meier, Neil T Young, Gillian Harcourt, Geoff Dusheiko

J Virol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers.
Maria Kantzanou, Michaela Lucas, Eleanor Barnes, Harvki Komatsu, Geoff Dusheiko

Immunol Lett· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetic analysis of hepatitis C virus transmission between injection drug users.
Alexandra Cochrane, Benjamin Searle, Alison Hardie, Roy Robertson, Toby Delahooke, Geoff M Dusheiko

J Infect Dis· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders.
Caroline A Sabin, Vince Emery, Helen L Devereux, Anja Griffioen, Jeremy Bishop, Geoff Dusheiko

J Med Virol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection.
Stephanie Reignat, George J M Webster, David Brown, Graham S Ogg, Abigail King, Geoff Dusheiko

J Exp Med· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis